Ballul Thomas, Belfeki Nabil, de Masson Adèle, Meignin Véronique, Woerther Paul-Louis, Martin Antoine, Poullot Elsa, Wargnier Alain, Fadlallah Jehane, Garzaro Margaux, Malphettes Marion, Fieschi Claire, Maisonobe Lucas, Bensekhri Hayat, Guillot Hélène, Bertinchamp Rémi, Jachiet Marie, Poirot Justine, Galicier Lionel, Oksenhendler Eric, Boutboul David
Clinical Immunology Department Hôpital Saint Louis, Université de Paris Paris France.
Internal Medicine Department Centre hospitalier de Melun Melun France.
EJHaem. 2021 Dec 23;3(1):175-179. doi: 10.1002/jha2.353. eCollection 2022 Feb.
Idiopathic multicentric Castleman disease (iMCD) is a lymphoproliferative disease of unknown etiology. Deciphering mechanisms involved in CD pathogenesis may help improving patients' care. Six cases of stereotyped sub-diaphragmatic iMCD affecting lower limb-draining areas and associated with severe and often ulcerative lower extremity chronic dermatological condition were identified in our cohort. Pathological examination revealed mixed or plasma-cell type MCD. In three patients, shotgun metagenomics failed to identify any pathogen in involved lymph nodes. Antibiotics had a suspensive effect while rituximab and tocilizumab failed to improve the condition. This novel entity requires a specific approach and exclusion of potentially harmful immunomodulation.
特发性多中心Castleman病(iMCD)是一种病因不明的淋巴增殖性疾病。解读Castleman病发病机制可能有助于改善患者的治疗。在我们的队列中,发现了6例典型的膈下iMCD,累及下肢引流区域,并伴有严重且常为溃疡性的下肢慢性皮肤病。病理检查显示为混合型或浆细胞型MCD。在3例患者中,鸟枪法宏基因组学未能在受累淋巴结中鉴定出任何病原体。抗生素有缓解作用,而利妥昔单抗和托珠单抗未能改善病情。这种新实体需要特定的治疗方法,并排除潜在有害的免疫调节。